Federal contractor · NEWARK, CA

DNA TWOPOINTO INC.

DNA TWOPOINTO INC. received $75K in federal contract obligations in FY2026, on 1 awards (0% vs FY2025). Since FY2017: $695.2K. Its largest customer was National Institutes of Health ($75K).

Obligations · FY2026
$75K
New awards
1
Sole-source
100%
Single offer
0.0%
UEI
G9S3SC8T5DM1
Parent company
DNA TWOPOINTO INC
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 47.6KFY2017
  2. 16KFY2018
  3. -12.4KFY2019
  4. 25KFY2020
  5. 201KFY2021
  6. 88KFY2022
  7. 105KFY2023
  8. 75KFY2024
  9. 75KFY2025
  10. 75KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$75K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$75K100%

Where the work was performed

  1. Alameda County, CA$75K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $75K
  • Sole-source awards100%
    US 30% · $75K
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY$300K
    National Institutes of Health· Alameda County, CA· Health & medical· May 12, 2023 – Jul 20, 2026· 75N93023P00594

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. MEDUNIK USA INC$210K
    PRINCETON, NJ · 93% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. GEMINI BIOPRODUCTS LLC$204.2K−100% in FY2026
    WEST SACRAMENTO, CA · 3 entities · 91% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. ADC THERAPEUTICS AMERICA, INC.$194K−100% in FY2026
    NEW PROVIDENCE, NJ · 86% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.